Ovarian wedge resection reduces androgen-producing stromal tissue in women with polycystic ovary syndrome who have failed medical ovulation induction, restoring spontaneous or treatment-responsive ovulatory cycles. Within NaProTECHNOLOGY, the procedure is performed with precise tissue economy and anti-adhesion technique to preserve ovarian reserve while correcting the underlying hormonal dysfunction identified through CrMS biomarker monitoring.
does ovarian wedge resection work for PCOS, PEARS ovarian wedge resection technique, surgery for polycystic ovaries to get pregnant, does wedge resection cause adhesions, clomiphene resistant PCOS surgical options, wedge resection vs medical treatment pregnancy rates PCOS, wedge resection androgen reduction polycystic ovaries, modern ovarian wedge resection without adhesions
Cite this article
Hilgers, T. W. (2004). Chapter 75: PEARS for Polycystic Ovaries: Ovarian Wedge Resection. The Medical and Surgical Practice of NaProTECHNOLOGY, 1023-1030.
Hilgers TW. Chapter 75: PEARS for Polycystic Ovaries: Ovarian Wedge Resection. The Medical and Surgical Practice of NaProTECHNOLOGY. 2004:1023-1030.
Hilgers, T. W. "Chapter 75: PEARS for Polycystic Ovaries: Ovarian Wedge Resection." The Medical and Surgical Practice of NaProTECHNOLOGY, 2004, pp. 1023-1030.
Hilgers TW, 2004·The Medical and Surgical Practice of NaProTECHNOLOGY
Surgical NaProTECHNOLOGY is defined as a cooperative surgical discipline that corrects reproductive pathology identified through CrMS monitoring and targeted diagnostic workup, employing microsurgical and laser techniques that maximize tissue preservation and minimize adhesion formation. The philosophical and technical distinctions from conventional gynecologic surgery are established, emphasizing restorative intent and anatomical precision as core principles.
Hilgers TW, 2004·The Medical and Surgical Practice of NaProTECHNOLOGY
Proximal tubal occlusion at the uterotubal junction, whether from salpingitis isthmica nodosa, fibrosis, or prior sterilization, requires cornual resection and microsurgical tubal reimplantation to re-establish luminal continuity. NaProTECHNOLOGY treats this as a reconstructive procedure rather than a reason to defer to IVF, and outcomes data support intrauterine pregnancy rates comparable to assisted reproduction in appropriately selected patients.
Hilgers TW, 2004·The Medical and Surgical Practice of NaProTECHNOLOGY
Infertility is not merely a reproductive inconvenience but frequently signals systemic or hormonal pathology — including polycystic ovarian disease, endometriosis, thyroid dysfunction, and immune abnormalities — each carrying independent health risks beyond failure to conceive. Identifying and treating these underlying conditions reduces long-term morbidity and reframes infertility evaluation as a form of preventive medicine rather than a terminal bypass decision.
NaProTECHNOLOGYInfertilityOvarian and Target Organ DysfunctionCervical Mucus
Hilgers TW, 2004·The Medical and Surgical Practice of NaProTECHNOLOGY
Ovarian dysfunction — encompassing luteal insufficiency, abnormal folliculogenesis, and anovulation — is treated in NaProTECHNOLOGY with cycle-timed interventions including HCG trigger, progesterone supplementation, clomiphene, and thyroid optimization, guided by prospective CrMS charting rather than protocol-driven stimulation. This approach normalizes endogenous hormonal patterns rather than overriding them, preserving uterine receptivity and reducing multiple gestation risk.